2026-01-22 - Analysis Report
**LLY: Eli Lilly Stock Analysis Report**
=====================================================

**Company Overview**
Eli Lilly and Company is a global pharmaceutical company that develops and manufactures medicines for various diseases.

**Return Rate Comparison**
-----------------------------

| Ticker | Cumulative Return |
|--------|-------------------|
| LLY    | 281.03%           |
| VOO    | 91.55%            |
| Divergence: 173.60 (relative divergence: 77.40%) |

**Divergence Analysis**
LLY stock has a significant divergence from the S&P 500 index, with a cumulative return rate that is 189.48% higher than the S&P 500 index.

**Alpha, Beta Analysis**
---------------------------

| | 2016-2018 | 2017-2019 | 2018-2020 | 2019-2021 | 2020-2022 | 2021-2023 | 2022-2024 | 2023-2025 |
|------------|------|------|------|------|------|------|------|------|
| CAGR       | 37.0% | 36.0% | 30.0% | 49.0% | 59.0% | 116.0% | 123.0% | 183.0% |
| MDD        | 14.3% | 14.7% | 20.9% | 20.9% | 20.9% | 18.0%  | 27.0%  | 29.9%  |
| Alpha      | 32.0% | 19.0% | 9.0%  | 5.0%  | 60.0% | 115.0% | 104.0% | 121.0% |
| Beta       | 0.7   | 0.7   | 0.7   | 0.7   | 0.7   | 0.5    | 0.6    | 0.7    |
| Cap(B)     | 103.7B | 117.8B | 151.4B | 247.6B | 328.0B | 522.6B | 692.1B  | 963.4B |

**Recent Stock Price Fluctuation**
---------------------------------

* Close: $1,078.52
* 5-day SMA: $1,052.89
* 20-day SMA: $1,070.07
* 60-day SMA: $1,017.17
* Market Risk Indicator (MRI): 0.80
* Recent price fluctuation indicates a sharp rebound.

**RSI, PPO Index Analysis**
---------------------------

* RSI: 49.77
* PPO: -0.50
* Recent (20 days) relative divergence change: -3.10 (worsening)
* 7-day Rank change: 2 (+) (rank up)
* 7-day Dynamic Expected Return change: -1.20 (-) (worsening)
* Expected Return: 57.10%

**Recent News & Significant Events**
-------------------------------------

* Why Eli Lilly (LLY) Stock Is Up Today - Yahoo Finance
* 3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026 - MarketBeat
* Abivax CEO Dismisses Rumors of Eli Lilly (LLY) Takeover as ‘Noise’ - TipRanks
* Eli Lilly: Buy Ahead Of Its Earnings Day (Preview) (NYSE:LLY) - Seeking Alpha
* Prediction: 2026 Will Be the Year of Eli Lilly - The Motley Fool
* Which Pharma Stock Stands Taller Right Now: LLY or PFE? - Yahoo Finance

**Analyst Opinions**
--------------------

* Key: Buy
* Mean (1=StrongBuy~5=Sell): 1.70 (~Buy)
* Opinions: 28
* Target Price (avg/high/low): 1110.71 / 1500.00 / 770.00

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
|-----|----|--------|
| 2025-10-30 | 6.22 | 17.60B |
| 2025-08-07 | 6.3  | 15.56B |
| 2025-05-01 | 3.07 | 12.73B |
| 2024-10-30 | 1.08 | 11.44B |

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.